Arcutis CEO’s 10B‑5 Plan Sale Sends Insider‑Selling Sparks Amid Volatile Stock
Arcutis Biotherapeutics insider sale: CMO Burnett Patrick sells 2,490 shares under a 10b‑5‑1 plan, hinting at short‑term liquidity amid volatile stock and uncertain earnings.
3 minutes to read